Aortic Regurgitation Clinical Trial
Official title:
Regional, Multicentric Registry of Aortic Valve-sparing Root Replacement, According to the Inclusion Technique Described by Tirone David
Retrospective observational study of all patients undergoing aortic root surgery with aortic valve conservation, using the inclusion technique described by Tirone David, between January 1, 2004 and December 31, 2020, at six centers (Nantes - Rennes - Brest - Angers - Tours [two centers]). The main objective of this study is to evaluate the survival without re-intervention for aortic valve dysfunction (surgery or TAVI).
Retrospective observational study of all patients undergoing aortic root surgery with aortic valve conservation, using the inclusion technique described by Tirone David. Inclusion criteria: Patients undergoing aortic root surgery with conservation of the aortic valve, according to the inclusion technique described by Tirone David, between January 1, 2004 and December 31, 2020, at one of the six centers: Nantes, Rennes, Brest, Angers, Tours (two centers). Non-inclusion criteria: Prosthetic replacement of the aortic valve intraoperatively during the first operation. Objectives and endpoints : - The survival without re-intervention for aortic valve dysfunction (surgery or TAVI) - The overall cardiovascular survival - The survival without aortic insufficiency of grade equal to or greater than two - The survival without aortic infective endocarditis - Assessment of long-term stroke risk Assessment of the risk of a major bleeding event in the long term Data analysis : The AORTLANTIC study is included in the EPICARD registry which is the official, national database of the French Society of Cardiac Surgery. Study data will then be collected using EPICARD's electronic Case Report Form (eCRF) and then analyzed using a multivariate Cox model. For the follow-up, the WEPI eCRF is used. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03314857 -
China XT: Safety and Effectiveness of Edwards Lifesciences SAPIEN XT THV in the Chinese Population
|
N/A | |
Completed |
NCT03666351 -
Study to Evaluate the Effect on Improvement of LVH by the Control of BP in Hypertension Patients With AV Disease
|
Phase 4 | |
Recruiting |
NCT06034028 -
J-Valve TF Early Feasibility Study
|
N/A | |
Active, not recruiting |
NCT03549091 -
Accuracy of Left Subclavian Regurgitation Evaluated by Ultrasound Doppler and 4D Flow MRI
|
N/A | |
Completed |
NCT01598844 -
JUPITER Study: Transapical Aortic Valve Implantation for Aortic Regurgitation
|
||
Active, not recruiting |
NCT03466918 -
China S3: Safety and Effectiveness of Edwards Lifesciences SAPIEN 3 THV in the Chinese Population
|
N/A | |
Active, not recruiting |
NCT04415047 -
The JenaValve ALIGN-AR Pivotal Trial
|
N/A | |
Not yet recruiting |
NCT05319171 -
Performance of Currently Available traNscaTHEter Aortic Valve Platforms in Inoperable Patients With Pure Aortic regurgitatiON of a Native Valve. The PANTHEON International Project.
|
||
Completed |
NCT05774795 -
LOng-Term Fate of Moderate Aortic Regurgitation Left Untreated at the Time of Mitral Valve Surgery
|
||
Terminated |
NCT02351726 -
Mitroflow DL Post Approval Study- North America
|
N/A | |
Completed |
NCT00624884 -
Velocity Vector Imaging in Patients With Moderate-to-Severe Aortic Regurgitation
|
N/A | |
Withdrawn |
NCT05409378 -
HLT® Meridian® TAVR Valve System Early Feasibility Study for Aortic Regurgitation
|
N/A | |
Recruiting |
NCT04038879 -
Comparison Study of Echocardiography and Cardiovascular Magnetic Resonance Imaging in the Assessment of Mitral and Aortic Regurgitation
|
||
Completed |
NCT05332184 -
Cardiac T1 Mapping Enables Risk Prediction of LV Dysfunction After Surgery for Aortic Regurgitation
|
||
Completed |
NCT01400841 -
HAART Model 300 Annuloplasty Ring
|
N/A | |
Not yet recruiting |
NCT02633423 -
Expiratory Flow Limitation and Mechanical Ventilation During Cardiopulmonary Bypass in Cardiac Surgery
|
N/A | |
Completed |
NCT00976625 -
Diastolic Dysfunction in Aortic Regurgitation
|
N/A | |
Enrolling by invitation |
NCT05714293 -
CT-evaluation of Coronary Ostia Height After Surgical Aortic Valve Replacement.
|
N/A | |
Recruiting |
NCT02974920 -
Rivaroxaban or Aspirin for Biological Aortic Prosthesis
|
Phase 4 | |
Not yet recruiting |
NCT03788590 -
Evaluate the Transcatheter Artificial Aortic Valve and Transcatheter Artificial Heart Values Delivery System
|
N/A |